• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱氨酰白三烯受体拮抗剂通过抑制毛细血管通透性来抑制肿瘤转移。

Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability.

作者信息

Nozaki Masako, Yoshikawa Masanobu, Ishitani Kunihiko, Kobayashi Hiroyuki, Houkin Kiyohiro, Imai Kohzoh, Ito Yoichiro, Muraki Takamura

机构信息

Department of Clinical Pharmacology, Tokai University School of Medicine, Kanagawa, Japan.

出版信息

Keio J Med. 2010;59(1):10-8. doi: 10.2302/kjm.59.10.

DOI:10.2302/kjm.59.10
PMID:20375653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3397318/
Abstract

We explored the possibility of the cysteinyl leukotriene receptor antagonists, pranlukast and montelukast, preventing tumor cell migration through both cerebral and peripheral capillaries. To study tumor cell migration through brain capillaries, male Fisher rats were cannulated via the cisterna magna under pentobarbital anesthesia. RCN9 cells labeled with a fluorescent marker PKH67 were intravenously administered following arachidonic acid administration into the subarachnoid space, and specimens of the central nervous system were collected every 30 min for 8 h. Arachidonic acid increased the fluid volume with elevated white blood cell and RCN9 cell counts. When given 2 h before arachidonic acid administration, pranlukast, but not montelukast, reduced the fluid volume and inhibited white blood cell and RCN9 cell extravasation through the brain capillary. In addition, a Lewis lung carcinoma metastasis model in mice was used to study the inhibitory effect of pranlu kast and montelukast against cancer cell extravasation through general capillaries. When mice were given food containing either pranlukast or montelukast, immediately after paw amputation, tumor metastasis was prevented by both drugs, and their survival was prolonged. These results show that pranlukast can inhibit tumor cell migration through both the brain and peripheral capillaries, whereas montelukast inhibits tumor cell migration only in the peripheral capillaries.

摘要

我们探究了半胱氨酰白三烯受体拮抗剂普仑司特和孟鲁司特通过脑毛细血管和外周毛细血管阻止肿瘤细胞迁移的可能性。为研究肿瘤细胞通过脑毛细血管的迁移情况,在戊巴比妥麻醉下,经枕大池对雄性Fisher大鼠进行插管。在向蛛网膜下腔注射花生四烯酸后,静脉注射用荧光标记物PKH67标记的RCN9细胞,每30分钟收集一次中枢神经系统标本,共收集8小时。花生四烯酸使液体量增加,白细胞和RCN9细胞计数升高。在花生四烯酸给药前2小时给予普仑司特(而非孟鲁司特),可减少液体量,并抑制白细胞和RCN9细胞通过脑毛细血管的渗出。此外,利用小鼠Lewis肺癌转移模型研究普仑司特和孟鲁司特对癌细胞通过全身毛细血管渗出的抑制作用。在小鼠爪子截肢后立即给予含普仑司特或孟鲁司特的食物,两种药物均可预防肿瘤转移,并延长其生存期。这些结果表明,普仑司特可抑制肿瘤细胞通过脑毛细血管和外周毛细血管的迁移,而孟鲁司特仅抑制肿瘤细胞在外周毛细血管的迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/05c2e1c2642a/nihms390059f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/ccaa7d83e083/nihms390059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/08d73a3b345f/nihms390059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/640574be1d87/nihms390059f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/d3abd4add8aa/nihms390059f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/833c6bd3d0a6/nihms390059f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/05c2e1c2642a/nihms390059f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/ccaa7d83e083/nihms390059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/08d73a3b345f/nihms390059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/640574be1d87/nihms390059f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/d3abd4add8aa/nihms390059f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/833c6bd3d0a6/nihms390059f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d54/3397318/05c2e1c2642a/nihms390059f6.jpg

相似文献

1
Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability.半胱氨酰白三烯受体拮抗剂通过抑制毛细血管通透性来抑制肿瘤转移。
Keio J Med. 2010;59(1):10-8. doi: 10.2302/kjm.59.10.
2
Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.半胱氨酰白三烯受体(CysLT)拮抗剂可减轻戊四氮诱导的癫痫发作和血脑屏障功能障碍。
Neuroscience. 2014 Sep 26;277:859-71. doi: 10.1016/j.neuroscience.2014.07.058. Epub 2014 Aug 1.
3
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.孟鲁司特,一种半胱氨酰白三烯受体-1拮抗剂,对小鼠局灶性脑缺血具有剂量和时间依赖性的保护作用。
Pharmacology. 2005 Jan;73(1):31-40. doi: 10.1159/000081072. Epub 2004 Sep 27.
4
Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.半胱氨酰白三烯受体 1 拮抗剂孟鲁司特钠可预防血脑屏障损伤。
Inflammopharmacology. 2019 Oct;27(5):933-940. doi: 10.1007/s10787-019-00611-7. Epub 2019 Jul 16.
5
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.孟鲁司特,半胱氨酰白三烯受体-1 拮抗剂,可减轻小鼠和大鼠局灶性脑缺血后的慢性脑损伤。
J Pharm Pharmacol. 2011 Apr;63(4):550-7. doi: 10.1111/j.2042-7158.2010.01238.x. Epub 2011 Mar 1.
6
[Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons].[半胱氨酰受体激动剂和拮抗剂对大鼠原代皮层神经元的影响]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Mar;36(2):117-22. doi: 10.3785/j.issn.1008-9292.2007.02.003.
7
Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.孟鲁司特钠,半胱氨酰白三烯受体 1 拮抗剂,对博来霉素诱导的肺纤维化小鼠发病机制的影响。
Eur J Pharmacol. 2011 Jan 10;650(1):424-30. doi: 10.1016/j.ejphar.2010.09.084. Epub 2010 Oct 27.
8
Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K channel pathway and PPARγ receptors.孟鲁司特,一种半胱氨酰白三烯受体拮抗剂,通过 L-精氨酸/一氧化氮/环鸟苷酸/K 通道途径和 PPARγ 受体在疼痛动物模型中发挥局部镇痛作用。
Int J Neurosci. 2021 Oct;131(10):1004-1011. doi: 10.1080/00207454.2020.1769618. Epub 2020 May 22.
9
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.半胱氨酰白三烯1型受体拮抗剂孟鲁司特与甲泼尼龙改善过敏性哮喘机制的比较研究
J Pharmacol Exp Ther. 2005 Feb;312(2):432-40. doi: 10.1124/jpet.104.074922. Epub 2004 Oct 6.
10
Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.白三烯受体拮抗剂孟鲁司特对多柔比星诱导的大鼠睾丸损伤的保护作用机制。
Prostaglandins Other Lipid Mediat. 2020 Aug;149:106447. doi: 10.1016/j.prostaglandins.2020.106447. Epub 2020 Mar 12.

引用本文的文献

1
-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers.驱动识别普仑司特作为PD-L1同型二聚体的稳定剂。
Anticancer Agents Med Chem. 2025;25(3):179-193. doi: 10.2174/0118715206303675241009104647.
2
Chemoprevention of esophageal adenocarcinoma in a rat surgical model by a cysteinyl leukotriene receptor‑1 antagonist.半胱氨酰白三烯受体-1拮抗剂在大鼠手术模型中对食管腺癌的化学预防作用
Oncol Lett. 2024 Feb 8;27(4):147. doi: 10.3892/ol.2024.14280. eCollection 2024 Apr.
3
Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression .孟鲁司特通过抑制半胱氨酰白三烯受体 1 表达抑制肺癌细胞迁移。
Curr Pharm Biotechnol. 2023;24(10):1335-1342. doi: 10.2174/1389201024666221207143513.
4
Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung.扎鲁司特阻断血小板 CysLT1R 受体可拮抗血小板促肿瘤作用并预防乳腺癌骨和肺转移。
Int J Mol Sci. 2022 Oct 13;23(20):12221. doi: 10.3390/ijms232012221.
5
Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.半胱氨酰白三烯受体拮抗剂与癌症发病率降低相关:一项回顾性队列研究。
Front Oncol. 2022 Apr 7;12:858855. doi: 10.3389/fonc.2022.858855. eCollection 2022.
6
Cysteinyl Leukotriene Pathway and Cancer.半胱氨酰白三烯途径与癌症。
Int J Mol Sci. 2021 Dec 23;23(1):120. doi: 10.3390/ijms23010120.
7
Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.普仑司特拮抗 CD49f 并降低三阴性乳腺癌细胞的干性。
Drug Des Devel Ther. 2020 May 12;14:1799-1811. doi: 10.2147/DDDT.S247730. eCollection 2020.
8
Expression of cysteinyl leukotriene receptor in brain tissues of rats with Streptococcus pneumoniae meningitis.肺炎链球菌性脑膜炎大鼠脑组织中半胱氨酰白三烯受体的表达
Int J Clin Exp Pathol. 2019 Dec 1;12(12):4242-4252. eCollection 2019.
9
Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.调节 2 型乳头状肾细胞癌中的 ATP 结合盒转运蛋白可增强其对靶向分子治疗的反应。
Mol Oncol. 2018 Oct;12(10):1673-1688. doi: 10.1002/1878-0261.12346. Epub 2018 Aug 23.
10
Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells.白三烯受体拮抗剂抑制三阴性乳腺癌细胞的促有丝分裂活性。
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):833-837. doi: 10.22034/APJCP.2018.19.3.833.

本文引用的文献

1
The role of leukotrienes in allergic rhinitis.白三烯在变应性鼻炎中的作用。
Ann Allergy Asthma Immunol. 2005 Jun;94(6):609-18; quiz 618-20, 669. doi: 10.1016/S1081-1206(10)61317-8.
2
Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.半胱氨酰白三烯受体拮抗剂通过降低血管内皮生长因子表达来调节血管通透性。
J Allergy Clin Immunol. 2004 Nov;114(5):1093-9. doi: 10.1016/j.jaci.2004.07.039.
3
Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.普仑司特给药对哮喘患者血管内皮生长因子水平的影响。
Chest. 2004 May;125(5):1700-5. doi: 10.1378/chest.125.5.1700.
4
The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study.半胱氨酰白三烯受体拮抗剂普仑司特在哮喘长期治疗中的地位:5年随访研究
Respiration. 2004 May-Jun;71(3):225-32. doi: 10.1159/000077419.
5
Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.西咪替丁可提高肿瘤细胞上唾液酸化Lewis-X和唾液酸化Lewis-A表位表达水平较高的结直肠癌患者的生存率。
Br J Cancer. 2002 Jan 21;86(2):161-7. doi: 10.1038/sj.bjc.6600048.
6
Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.半胱氨酰白三烯的病理生理学及白三烯受体拮抗剂在哮喘中的作用
Allergy. 2001;56 Suppl 66:7-11. doi: 10.1034/j.1398-9995.56.s66.2.x.
7
Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats.介质在卵清蛋白致敏的棕色挪威大鼠气道中抗原诱导的支气管痉挛和微血管渗漏中的作用。
Br J Pharmacol. 2001 Jan;132(2):481-8. doi: 10.1038/sj.bjp.0703847.
8
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression.西咪替丁通过阻断E-选择素的表达来抑制癌细胞与内皮细胞的黏附并防止转移。
Cancer Res. 2000 Jul 15;60(14):3978-84.
9
Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.半胱氨酰白三烯受体拮抗剂普仑司特和扎鲁司特对卵清蛋白致敏豚鼠气管黏液分泌的体外作用
Br J Pharmacol. 1998 Jun;124(3):563-71. doi: 10.1038/sj.bjp.0701886.
10
Antileukotriene agents.抗白三烯药物。
Curr Opin Pulm Med. 1997 May;3(3):215-20. doi: 10.1097/00063198-199705000-00006.